XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements (Additional Information) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 21, 2023
Nov. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]              
Principle amount of issued debt         $ 25,000    
Change in fair value of convertible debentures     $ 3,748 $ 0 3,748 $ 0  
Loss (gain) on derivative liability     $ 82 $ 2,700 5,335 $ (4,800)  
Common stock upon conversation of cash         $ 3,000    
Discount rate of FDA     10.60%   10.60%    
Development Milestone Payment         $ 200   $ 200
Derivative warrant liability private warrants         6,600    
Equity Unit Purchase Agreements [Member]              
Subsidiary, Sale of Stock [Line Items]              
Principle amount of issued debt         $ 25,000    
Convertible Debenture principal Amount $ 25,000            
Private Placement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Derivative warrant liability private warrants   $ 2,500          
Securities Purchase Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Principle amount of issued debt $ 25,000